Zoetis | ZTS - Operating Profit




Zoetis reported $732M in Operating Profit for its fiscal quarter ending in December of 2024.

Operating Profit Change Date
AbbVie USD -1490000000 5.4B Dec/2024
Align Technology USD 144.15M 18.21M Dec/2024
Bayer EUR -3822000000 4.35B Sep/2024
Bristol-Myers Squibb USD 510M 1.66B Dec/2024
Charles River Laboratories USD 117.4M 52.9M Sep/2024
Dentsply International USD -462000000 533M Sep/2024
Eli Lilly USD 5.15B 714.4M Dec/2024
Henry Schein USD 157M 17M Sep/2024
Idexx Laboratories USD 261.69M 42.2M Dec/2024
Illumina USD 175M 566M Dec/2024
IQVIA Holdings USD 622M 72M Dec/2024
J&J USD 3.89B 549M Dec/2024
Laboratory Of America USD 216.5M 55.6M Dec/2024
Merck USD 4.22B 266M Dec/2024
Neogen USD 3.91M 1.65M Nov/2024
Pacira USD -139527000 170.51M Sep/2024
Patterson Companies USD 37.64M 0 Oct/2024
Perrigo USD 75.3M 30.3M Sep/2024
Pfizer USD -409000000 5.69B Dec/2024
Quest Diagnostics USD 361M 8M Dec/2024
Sanofi EUR 4.09B 1.81B Sep/2024
Sanofi EUR 3.64B 1.35B Sep/2024
Zoetis USD 732M 675M Dec/2024